Study of safety and efficacy of autologous platelet rich plasma combined with fractional CO2 laser in the treatment of post acne scars: a comparative simultaneous split-face study

Sidhartha D. Shah; Bipin D. Mehta; Milind A. Borkar; Reshma C. Aswani

doi:10.18203/2320-6012.ijrms20171224

Authors

Sidhartha D. Shah Department of Dermatology, NKP Salve Institute of Medical Science and Research Center, Nagpur, Maharashtra, India
Bipin D. Mehta Department of Dermatology, NKP Salve Institute of Medical Science and Research Center, Nagpur, Maharashtra, India
Milind A. Borkar Department of Dermatology, NKP Salve Institute of Medical Science and Research Center, Nagpur, Maharashtra, India
Reshma C. Aswani Department of Dermatology, NKP Salve Institute of Medical Science and Research Center, Nagpur, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20171224

Keywords:

Acne scars, Adverse effects Autologus PRP, Fractional CO2 laser

Abstract

Background: Many treatments are available for treating post acne scars but optimized treatment does not exist still. Hence, this study was conducted with the aim to evaluate the safety and efficacy of autologous platelet rich plasma combined with fractional CO₂ laser for treatment of acne scars when used in Indian skin.

Methods: Thirty patients attended to the Dermatology OPD were enrolled in the study after meeting inclusion criteria. They underwent split-face therapy. They received ablative fractional carbon dioxide (CO₂) laser combined with autologous platelet-rich plasma (PRP) treatment on one half of their face and ablative fractional CO₂ laser with intradermal normal saline on the other half. The injections were administered immediately after laser therapy. Each participant received 4 treatments spaced by 1 month and were followed up for a period of 4 months.

Results: The outcome among the study subjects were assessed using Goodman and Baron Scale at different time intervals. Significant reduction in acne scars was observed in both PRP injection site and normal saline injection site but better reduction of acne scars was noted at the PRP site. The blinded physician’s assessment and patient satisfaction was better at PRP injected side as compared to the normal saline injected side. The incidence of adverse effects and pain during the procedure was significantly lower in PRP injected side compared normal saline injected side.

Conclusions: This study demonstrated that PRP should be considered as an adjuvant therapeutic option for dermatologic procedures such as fractional CO₂ laser resurfacing for treatment of post acne scars as it might have additional benefit of reducing the adverse effects such as persistent erythema and edema.

Metrics

Metrics Loading ...

References

Rivera AE. Acne scarring: a review and current treatment modalities. J Am Acad Dermatol. 200859(4):659-76.

Kadunc BV, de Almeida ART. Surgical treatment of facial acne scars based on morphologic classification: a brazilian experience. Dermatol Surg. 2003;29(12):1200-9.

Dreno B, Khammari A, Orain N, Noray C, Merial-Kieny C, Mery S, et al. Ecca grading scale: an original validated acne scar grading scale for clinical practice in dermatology. Dermatol. 2006;214(1):46-51.

Loney T, Standage M, Lewis S. Not just 'skin deep': Psychosocial effects of dermatological-related social anxiety in a sample of acne patients. J Health Psychol. 2008;13:47-54.

Geronemus RG. Fractional photo-thermolysis: Current and future applications. Lasers Surg Med. 2006;38:169-76.

Sardana K, Garg VK, Arora P, Khurana N. Histological validity and clinical evidence for use of fractional lasers for acne scars. J Cutaneous Aesthetic Surg. 2012;5(2):75.

Lee JW, Kim BJ, Kim MN, Mun SK. The efficacy of autologous platelet rich plasma combined with ablative carbon dioxide fractional resurfacing for acne scars: A simultaneous split-face trial. Dermatol Surg. 2011;37:931-8.

Cervelli V, Nicoli F, Spallone D, Verardi S, Sorge R, Nicoli M, et al. Treatment of traumatic scars using fat grafts mixed with platelet-rich plasma, and resurfacing of skin with the 1540 nm nonablative laser. Clin Exp Dermatol. 2012;37:55-61.

Gawdat HI, Hegazy RA, Fawzy MM, Fathy M. Autologous platelet rich plasma: Topical versus intradermal after fractional ablative carbon dioxide laser treatment of atrophic acne scars. Dermatol Surg. 2014;40:152-61.

Nita AC, Orzan OA, Filipescu M, Jianu D. Fat graft, laser CO2 and platelet-rich-plasma synergy in scars treatment. J Med Life. 2013;6:430-3.

Nofal E, Helmy A, Nofal A, Alakad R, Nasr M. Platelet-rich plasma versus CROSS technique with 100% trichloroacetic acid versus combined skin needling and platelet rich plasma in the treatment of atrophic acne scars: A comparative study. Dermatol Surg. 2014;40:864-73.

Boswell SG, Cole BJ, Sundman EA, Karas V, Fortier LA. Platelet-rich plasma: A milieu of bioactive factors. Arthroscopy. 2012;28:429-39.

Lacci KM, Dardik A. Platelet-rich plasma: Support for its use in wound healing. Yale J Biol Med. 2010;83:1-9.

Cho JW, Kim SA, Lee KS. Platelet-rich plasma induces increased expression of G1 cell cycle regulators, type I collagen, and matrix metalloproteinase-1 in human skin fibroblasts. Int J Mol Med. 2012;29:32-6.

Kim SA, Ryu HW, Lee KS, Cho JW. Application of platelet-rich plasma accelerates the wound healing process in acute and chronic ulcers through rapid migration and upregulation of cyclin A and CDK4 in HaCaT cells. Mol Med Rep. 2013;7:476-80.

Goodman GJ, Baron JA. Postacne scarring–a quantitative global scarring grading system. J Cosmetic Dermatol. 2006;5(1):48–52.

Sanchez FH. Treatment of Acne Scars, in Dermatologic Surgery: Step by Step. Oxford, UK: Wiley-Blackwell; 2012: 195–206.

Fife DJ, Fitzpatrick RE, Zachary CB. Complications of fractional CO2 laser resurfacing: four cases. Lasers Surgery Med. 2009;41(3):179-84.

Eppley BL, Pietrzak WS, Blanton M. Platelet-rich plasma: a review of biology and applications in plastic surgery. Plastic Reconstructive Surg. 2006;118(6):147-59.

Smith RG, Gassmann CJ, Campbell MS. Platelet-rich Plasma: Properties and Clinical Applications. J Lancaster General Hospital. 2007;2(2):73-8.

Faghihi G, Nouraei S, Asilian A, Keyvan S, Abtahi-Naeini B, Rakhshanpour M, et al. Efficacy of punch elevation combined with fractional carbon dioxide laser resurfacing in facial atrophic acne scarring: A randomized split-face clinical study. Dermato Surg Round. 2015;60(5):473-8.

Faghihi G, Keyvan S, Asilian A, Nouraei S, Behfar S, Nilforoushzadeh MA, et al. Efficacy of autologous platelet-rich plasma combined with fractional ablative carbon dioxide resurfacing laser in treatment of facial atrophic acne scars: A split-face randomized clinical trial. Indian J Dermatol, Venereol, Leprol. 2016;82(2):162.

Na JI, Choi JW, Choi HR, Jeong JB, Park KC, Youn SW, et al. Rapid healing and reduced erythema after ablative fractional carbon dioxide laser resurfacing combined with the application of autologous platelet-rich plasma. Dermatol Surg. 2011;37(4):463.

Sampson S, Gerhardt M, Mandelbaum B. Platelet rich plasma injection grafts for musculoskeletal injuries: a review. Curr Rev Musculoskeletal Med. 2008;1(3-4):165–74.

Marx RE. Platelet-rich plasma: Evidence to support its use. J Oral Maxillofac Surg. 2004;62:489-96.

Robiony M, Polini F, Costa F, Politi M. Osteogenesis distraction and platelet-rich plasma for bone restoration of the severely atrophic mandible: Preliminary results. J Oral Maxillofac Surg. 2002;60:630-5.

Shin MK, Lee JH, Lee SJ, Kim NI. Platelet-rich plasma combined with fractional laser therapy for skin rejuvenation. Dermatol Surg. 2012;38(4):623-30.

Mahindra P, Yamin M, Selhi HS, Singla S, Soni A. Chronic plantar fasciitis: Effect of platelet-rich plasma, corticosteroid, and placebo. Orthopedics. 2016;39(2):285-9.

Khoshbin A, Leroux T, Wasserstein D, Marks P, Theodoropoulos J, Ogilvie-Harris D, et al. The efficacy of platelet-rich plasma in the treatment of symptomatic knee osteoarthritis: a systematic review with quantitative synthesis. Arthroscopy: J Arthroscopic Rel Surg. 2013;29(12):2037-48.

Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med. 2006;34(11):1774-8.